IL33 and Cognitive impairment: Additionally, in a murine model of ECM, IL-33 induced the release of Th2 cytokines IL-4, IL-5, and IL-13, as well as the expansion of Tregs, while suppressing the pro-inflammatory response, which alleviated cognitive impairment and prevented ECM development [3, 79].